Peer Review History
| Original SubmissionMarch 2, 2021 |
|---|
|
PONE-D-21-06856 Improving Responsiveness and Financial Protection in Government-Funded Health Insurance Scheme in India: Evidence from Early Implementation of Pradhan Mantri Jan Aarogya Yojana (AB – PMJAY) PLOS ONE Dear Dr. Trivedi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The major comment from all the reviewers is requirement of a more succinct and structured presentation of the manuscript. It requires results and discussion to clearly follow from the objectives of the study. The variables/ indicators need to be clearly defined for responsiveness, quality and financial protection in the methodology section. My own specific comments are added below and also in the attached manuscript. The grammar, references and abbreviations must clearly follow the PLOS One style of writing. Please submit your revised manuscript by May 16 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Charu C Garg, Ph.D. Academic Editor PLOS ONE Additional Editor Comments: Studying responsiveness, quality and financial protection for the newly launched PMJAY scheme will add value to Indian policy and is useful for international literature to know factors that influence these attributes for government insurance schemes. However, the paper needs to be better structured to follow it more clearly, especially for international audience. There are several Grammatical issues and certain sections are really lengthy. The discussion and conclusion section needs to be better linked to results. The indicators under responsiveness, quality and financial protection must be explained upfront. The abstract needs to be rewritten with clear results and conclusions. Abstract needs revision. Does not present any results from the text and conclusion does not follow from the result. The title does not have quality, but you do mention about quality in results. if it is part of responsiveness, please say it clearly. Also AB in the title is not explained or used throughout the manuscript. Very long introduction, needs to be structured with background linked to objectives studied. In the methods section, clearly explain the variables/ indicators used for responsiveness, quality and financial protection used in your study. The indicators are mixed up under the procedures - from admission to discharge to follow up. EG. section c has a mix of responsiveness and financial protection in results. Use the same format then for results and discussion. These are given but the presentation needs to be clearer for the reader to follow. There are several issues in the result section, which have been put as comments in the paper and need to be explained. Discussion needs to be arranged in the context of major sections studied, what your research says and how does it corroborate with the research from other government health sponsored schemes from past in INDIA such as RSBY or state insurance schemes or other countries. In what ways PMJAY is better than existing insurance schemes and what needs to be improved. Please see more specific comments in the attached document. Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. 3. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified how verbal consent was documented and witnessed. 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 6. We noted in your submission details that a portion of your manuscript may have been presented or published elsewhere. [the contents of this manuscript have not been submitted for publication elsewhere. A modified version of this manuscript is available as a working paper on https://pmjay.gov.in/sites/default/files/2020-02/WP_IIPH_study_2.pdf.] Please clarify whether this publication was peer-reviewed and formally published. If this work was previously peer-reviewed and published, in the cover letter please provide the reason that this work does not constitute dual publication and should be included in the current manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: General comments: The manuscript reviews major language editing and rewriting. There are far too many language errors across the manuscript, which makes it non readable. All sections need major editing and shortening. The repetition should be eliminated. The discussion section needs to be improved with editing and in the quality of analysis. Specific comments: Abstract need to be completely re-written. It does not capture the essence of manuscript. There are 200 study participants from whom data was collected. Some quantitative analysis findings should be part of the abstract, which currently focuses upon qualitative aspects only. The conclusion in abstract is generic. Please re-write. The acronyms can be avoided. Financial disclosure: Please confirm if this is full disclosure of grant or was there any other funding in addition to Health policy and system research at WHO HQ? Please also confirm if authors have acknowledged all the key people who contributed to this work? Ethical statement: was there any specific reason that only verbal consent was sought and not the written consent? Introduction / main text: The language need major re-writing for academic standards. The wordings such as ; line 3: ‘people may remain unhappy with the health systems” could be avoided. This section is a bit superfluous and verbose. It need to edited and shortened. There are total 108 lines, it is difficult to follow and read. The information about PM-AY can be moved into a box. Methods section, there is duplication of information and repetitions. Results section. One of the limitations is that the small sample size and then then findings have been used in both tables and text. In discussion, the key actionable suggestions should be included. The limitations of this work need to be elaborated. More India specific literature review and citations should be used. Conclusion: Should be succinct and single or maximum two paragraphs. Figure 1- 4 are repetition and can be removed. Reviewer #2: while the theme chosen is good, I have the following observations: 1. The paper may give some context of health care utilization and expenditure about the states chosen 2.Need to strengthen the discussion section with some comparison of the findings of PM-JAY with private health insurance schemes to judge the strengths and shortcomings of PM-JAY. 3. Quantitative analysis may be augmented by estimating odds-ratios for the chosen indicators. 4. The word "improving" may be dropped from the title. 5. There are many grammatical errors and many sentences need editing to have a more terse presentation. 6. in line 251, the figures in the Table and in the description do not match. 7. Line 274, and other lines, the style of writing figures is not uniform. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Chandrakant Lahariya Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-21-06856R1Responsiveness and Financial Protection in a Government-Funded Health Insurance Scheme: Evidence from Early Implementation of Pradhan Mantri Jan Aarogya Yojana (PM-JAY) in IndiaPLOS ONE Dear Dr. Trivedi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The revision has addressed some comments, however the paper still does not meet the standard of the journal in terms of rigorous statistical analysis. Many comments from of the previous reviewers are still not met which have also been raised by the secondary reviewer chosen for this revision. The abstract is still vague with conclusions not following from results. None of the conclusion and seem to cater to the international audience and are very broad even for Indian perspective. Further the discussion section is still very weak and does not clearly discuss the results from the study in comparison to similar studies internationally or in comparison to the control population – that is those who did not benefit from the PMJAY scheme. Please submit your revised manuscript by Oct 19 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Charu C Garg, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (if provided): The title has responsiveness and financial protection. please discuss these clearly. Abstract is still very vague. The introduction must have the objective linked to the title. Methods must state how are responsiveness and financial protection studied in the context of PMJAY scheme. Results should be linked clearly to the indicators measured and conclusion should be linked to the results. Conclusion: there are unnecessary sentences in the conclusion. Eg. The statement “This study provides insights from its beneficiaries based on their experiences of hospitalization under PM-JAY” —this is objective and not conclusion. Need to clearly say what GSHIS did to improve responsiveness and what was the outcome or the result of that and what can India and other counties learn from the experience. Please rewrite the abstract clearly Introduction: Liner 95 – not clear - 500 million beneficiaries from the 100 million poor and vulnerable families Last para of introduction could clearly state how responsiveness and financial protection would be studied. Especially there is nothing about financial protection in the introduction. Table 1: the data should not be a part of the methodology. Even if is based on secondary sources, these are results. However not being a part of the main study, these could be supplementary material and the figures can be used in the context of responsiveness and financial protection in discussion. The hospital OOP data can be found in the latest version of the NSSO key indicators for 2017-18. Plus, the OOP differs when hospitalization is in public or private facilities and in rural and urban areas. The NHA data is also dated and available for more recent years Methods: Still; very weak to compare the two states. No clear statistical analysis to understand the differences in the two states. Just presenting table 1 in methods does not show how the results are compared across two states and why the differences are observed. It’s just data presented from a survey with no good analysis. Can the results be compared with control population, those who had similar hospitalization episodes but were not a part of PMJAY scheme. Results: Why are the n in tables 4 and 5 different. Tables 4 and 5 can be combined. There are no control variables to say whether the PMJAY was more responsive or not. Discussion: Lines 370-371 add OOPE also. The discussion should be clearly organized first around the variables for responsiveness providing quantitative comparison with the studies from India and international. Why do you say PMJAY is more responsive – in comparison to what. Also then compare financial protection the same way. Lines 383, can you pls compare with the references mentioned in quantitative terms to provide a perspective of improvement. In providing the information to patients. Lines 389-90: Do you mean overall in both states public sector hospitals performed better. Discussions should clearly bring out reasons for differences in waiting times at the public and private sector and reasons for it. Also compare quantitatively with other studies to show whether the waiting time mentioned is responsive. Line 401- you mention short waiting time- but it was 3 hours in private sector in MP. That is not short. Lines 406-420. OOP discussion should again be in perspective with non-insured patients and also insured in other programs. Why is PMJAY better. The para provides a weak discussion. There are still a lot of repetition in conclusions and needs to be a para highlighting important points. Is there a rural urban variation in responsiveness and financial protection? Why are there such varied results between two states. What is working in one state and not the other? The paper is important but still not convincing enough. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: The authors have addressed the comments raised in the review, revised the language and grammar and the paper may be accepted now. Reviewer #3: Thanks for taking up an interesting topic on evaluation of delivery of Government Health Insurance Schemes to poor which was revised and re-launched in Sept 2018. I have reviewed the revised version of the paper and looking at previous reviewers comments I would like to state that all comments are not adequately addressed. My additional comments are as follows. 1. Abstract need a thorough revision which I agree with previous reviewers. 2. Neither objectives nor main outcome measurements were clearly defined in the paper as well as in the abstract. Conclusion seems don't appear from the findings of the survey. 3. No statistical tools were applied to explain differences in two states or controlling for hospital types. 4. It appears sample is biased when we talk about share of SC & ST patients in Madhya Pradesh. 5. The major flaw is in the sample selection procedure where the just did quota sampling from two tales of the patients hospitalised during April 2019 in 14 hospitals. One can't portray a robust picture using top 10% and bottom 10% of patients using services as "Highest"/ "Lowest" consumption of health care resources in the sampled hospitals. Instead of following a randomisation process they eliminated the middle 80% of cases. 6. I have mentioned comments on the body of paper and on tables; e.g. I can't understand they are using "Total" heading in both columns and rows even whilst presenting statistics on average for two states. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: Yes: Anil Gumber [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Experiences and challenges in accessing hospitalization in a Government-Funded Health Insurance Scheme: Evidence from Early Implementation of Pradhan Mantri Jan Aarogya Yojana (PM-JAY) in India PONE-D-21-06856R2 Dear Dr. Trivedi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Charu C Garg, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): As suggested by the reviewer as well, professional English editing can help the paper to be more crisp and bring further clarity. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: Most of my comments are addressed. I think the manuscript still needs English Editing. Tables titles need more clarity. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: Yes: Anil Gumber |
| Formally Accepted |
|
PONE-D-21-06856R2 Experiences and challenges in accessing hospitalization in a Government-Funded Health Insurance Scheme: Evidence from Early Implementation of Pradhan Mantri Jan Aarogya Yojana (PM-JAY) in India Dear Dr. Trivedi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Charu C Garg Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .